Microbiology & Serology
Microbiology & Serology        
VITEK 2 Compact  
alt An Introduction
  • VITEK 2 Compact is a sophisticated state of art automated microbial identification and susceptibility testing systems.
  • It is powered by the Advanced Expert System (AES) software, which validates and interprets susceptibility test results, and detects antibiotic resistance mechanisms.
  • VITEK 2 Compact provides timely, relevant information for targeted antibiotic therapy, resulting in improved patient care and lower healthcare expenses. Beneficiaries of this system are microbiologist, the clinician and ultimately, the patient.
  • In addition to optimized result reliability, the microbiologist can be confident of detecting antibiotic resistance and even weakly expressed resistance mechanisms.
  • This report helps the clinician to make the correct diagnosis and, when necessary, adapt the antibiotic therapy at the earliest possible stage.
  • The patient benefits from timely treatment with the most relevant antibiotics.
  • This expert software is capable of identifying antibiotic resistance mechanisms, even emerging and low-level resistance.
  • It also contributes to the detection of nosocomial infections, enabling proactive measures to be implemented.

Antimicrobial Resistance and Nosocomial Infections
  • Following the widespread availability of newly discovered antibiotics in the 1940s, the number of illnesses and deaths from infectious diseases fell dramatically.
  • However, bacteria have since been able to develop resistance to existing antibiotic treatments. The development of "multi-resistant" bacteria (such as Staphylococcus aureus and Enterococci), which can be resistant to even second or third generation antibiotics, represents an important healthcare challenge.
  • Antimicrobial resistance often concerns nosocomial infections, which are now a leading cause of death in some countries, with up to 60 % of hospital infections caused by multi-resistant microbes.
  • In the US, it is estimated that 14,000 patients die every year from hospital-acquired antibiotic -resistant bacteria. The number may be many times more in India.
  • Antimicrobial resistance also significantly impacts healthcare expenditure, since the treatment of resistant bacteria requires prolonged hospital stays and often patient isolation.
BacT Alert 3D
from bioMerieux France
alt BacT Alert 3D is capable of reporting
  • Rapid Blood Culture (Pyogenic) within 9-24 hours
  • Rapid Mycobacterium Culture within 9-14 days
  • Mycobacterium Sensitivity within 9-14 days